IGM BIOSCIENCES
Summary
IGM Biosciences is a biotechnology company focused on developing and commercializing a new class of antibody-based therapeutics, specifically IgM antibodies, for the treatment of cancer and autoimmune and inflammatory diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 60 M
Avg. Deal Size£ 60 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite